Amebiasis Market Size Projected To Reach 1.13 Billion By 2034 With A Cagr Of 6.6%

We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.

What Is the Projected Growth of the Amebiasis Market?
The market for amebiasis has been on a strong upward trend of late. The prediction is for it to escalate from $0.82 billion in 2024 to $0.88 billion in 2025, reflecting a 6.9% compound annual growth rate (CAGR). This growth surge in previous years can be linked to escalating rates of amoeba-related infections in warm climate regions, lax sanitation, and inadequate hygiene habits in developing nations, increased overseas travel particularly to areas where the disease is prevalent, heightened disease awareness, and a shortage of uncontaminated drinking water in rural locations.

The amebiasis market is anticipated to witness robust growth over the next few years, expanding to $1.14 billion by 2029, with a Compound Annual Growth Rate (CAGR) of 6.6%. The expected growth within the forecast period can be credited to the rising numbers of immune-compromised individuals, enhanced governmental actions towards bettering sanitation and healare infrastructure, increased funding in researching innovative treatments, an amplified focus on health projects aimed at fighting parasitic illnesses, and a surging requirement for efficient oral drugs. The forecast period is poised to experience major trends such as rising acceptance of combination therapies, vaccine development, advancements in systems for drug delivery, progress in pharmaceutical research, and the creation of novel antiprotozoal pharmaceuticals.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21094

What Are the Different Amebiasis Market Segments?
The amebiasis market covered in this report is segmented -

1) By Type: Metronidazole, Paromomycin, Tinidazole
2) By Route Of Administration: Oral, Intravenous
3) By Application: Hospital, Pharmacy

Subsegments:
1) By Metronidazole: Oral Metronidazole, Intravenous Metronidazole, Combination Therapy with Metronidazole
2) By Paromomycin: Oral Paromomycin, Paromomycin in Combination with Other Drugs
3) By Tinidazole: Oral Tinidazole, Tinidazole for Severe Infections

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21094&type=smp

What Are the Primary Drivers Shaping the Amebiasis Market?
The uptrend in parasitic infections is projected to fuel the expansion of the amebiasis market. The term "parasitic infections" alludes to ailments caused by parasites including protozoa, helminths, and ectoparasites that subsist within or on a host, consuming nutrients to the host's detriment. The rise in parasitic infections can be attributed to factors such as heightened travel, climate change, inadequate sanitation, and increasing drug resistance, all of which collectively facilitate the spread and persistence of these infections. Amebiasis, a disease triggered by the entamoeba histolytica parasite, amplifies parasitic infections by infiltrating the intestines, causing symptoms like diarrhea, abdominal pain and may lead to grave consequences like tissue destruction and liver abscesses. For example, as per the UK-based Animal and Plant Health Agency in January 2024, a total of 1,071 Parasitic Gastroenteritis (PGE) diagnosises were recorded in 2022, inclusive of 190 haemonchosis cases and 95 nematodirosis cases. The caseload of haemonchosis was noticeably elevated compared to the previous year in 2022. Hence, the escalating figures of parasitic infections are enhancing the growth of the amebiasis market. The Impact Of Substandard Sanitation On Market Advancement

Which Companies Are Leading in the Amebiasis Market?
Major companies operating in the amebiasis market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Sanofi SA, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Novartis AG, F. Hoffmann-La Roche Ltd, Eli Lilly and Company, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, Siemens Healthineers AG, Becton inson and Company, Teva Pharmaceutical Industries Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, Lupin Limited, Cepheid Inc., Mission Pharmacal Company, Profounda Inc., Zydus Lifesciences Limited

What Trends Are Driving Growth in The Amebiasis Market?
Key players in the amebiasis market are emphasizing the development of enhanced solutions such as ready-to-use oral liquid metronidazole to boost patient adherence and treatment effectiveness. The ready-to-use oral liquid metronidazole is a pre-made liquid antibiotic used for treating infections like amebiasis, providing an easier option for patients who find it hard to swallow tablets. For example, in November 2023, Kesin Pharma Corporation, an American pharmaceutical firm, got the green light from the U.S. Food and Drug Administration for its product, Likmez (metronidazole) oral suspension, in a 500 mg/5 mL dosage - the first ready-to-use oral liquid version of metronidazole. The formulation is child-friendly, making medication intake more manageable and ensuring correct dosing for children, which leads to higher adherence to treatment regimens. The liquid version provides dosage flexibility, permitting healare practitioners to modify treatment according to the specific needs of the patient, especially in cases of varying infection severity.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/amebiasis-global-market-report

What Are the Top Revenue-Generating Geographies in the Amebiasis Market?
North America was the largest region in the amebiasis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the amebiasis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Amebiasis Market?
2. What is the CAGR expected in the Amebiasis Market?
3. What Are the Key Innovations Transforming the Amebiasis Industry?
4. Which Region Is Leading the Amebiasis Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.